drugset / Trial / NCT01451606
Duloxetine for the Treatment of Chronic Pelvic Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is examining the effectiveness of duloxetine as a treatment for chronic pelvic pain in women. Duloxetine is FDA approved for the treatment of other pain conditions, including fibromyalgia and diabetic neuropathy.
Timeline
- Start
- 2011-07-11
- Primary completion
- 2015-11-04
- Completion
- 2015-11-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Duloxetine | Small molecule | 60 mg | Oral |